Literature DB >> 3980085

Simultaneous loss of bacteriophage receptor and coaggregation mediator activities in Actinomyces viscosus MG-1.

C A Tylenda, E Enriquez, P E Kolenbrander, A L Delisle.   

Abstract

Actinomyces bacteriophages were used as tools to study coaggregation between actinomyces and streptococci. Four bacteriophage isolates, phages AV-1, AV-2, AV-3, and 1281, bound to coaggregation group A Actinomyces viscosus and to group E A. naeslundii. No binding to groups B, C, D, or F was observed. Only A. viscosus MG-1 was capable of supporting a productive infection by these phages. Spontaneously occurring bacteriophage-resistant mutants of A. viscosus MG-1 were isolated and were shown to fall into two classes. Class I mutants were resistant to all four phages, whereas class II mutants were resistant only to phage AV-3. In each case, strains resistant to a particular phage were unable to bind that phage, suggesting that a loss or alteration of the cell surface phage receptor had occurred. Both classes of mutants were unable to coaggregate with streptococci representing coaggregation group 1 and had also lost the ability to mediate one type of coaggregation with group 4 streptococci. Class II mutants also were unable to coaggregate with group 2 streptococci. Lactose-inhibitable interactions with other streptococci (groups 3 and 4) were unchanged in the mutants. The simultaneous loss of sensitivity to phage AV-3 and the ability to coaggregate with coaggregation group 1 streptococci suggests the possibility of a relationship between these two cell surface structures.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3980085      PMCID: PMC261939          DOI: 10.1128/iai.48.1.228-233.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  9 in total

1.  Lactose-reversible coaggregation between oral actinomycetes and Streptococcus sanguis.

Authors:  P E Kolenbrander; B L Williams
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

2.  Isolation of a bacteriophage for actinomyces viscosus.

Authors:  A L Delisle; R K Nauman; G E Minah
Journal:  Infect Immun       Date:  1978-04       Impact factor: 3.441

3.  Specific absence of type 2 fimbriae on a coaggregation-defective mutant of Actinomyces viscosus T14V.

Authors:  J O Cisar; S H Curl; P E Kolenbrander; A E Vatter
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

4.  Characterization of a galactose-specific lectin from Actinomyces viscosus by a model aggregation system.

Authors:  M J Heeb; A H Costello; O Gabriel
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

5.  Bacteriophage that can distinguish between wild-type Rhizobium japonicum and a non-nodulating mutant.

Authors:  G Stacey; L A Pocratsky; V Puvanesarajah
Journal:  Appl Environ Microbiol       Date:  1984-07       Impact factor: 4.792

6.  Specificity of coaggregation reactions between human oral streptococci and strains of Actinomyces viscosus or Actinomyces naeslundii.

Authors:  J O Cisar; P E Kolenbrander; F C McIntire
Journal:  Infect Immun       Date:  1979-06       Impact factor: 3.441

7.  Isolation and characterization of coaggregation-defective mutants of Actinomyces viscosus, Actinomyces naeslundii, and Streptococcus sanguis.

Authors:  P E Kolenbrander
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

8.  New Actinomyces and Streptococcus coaggregation groups among human oral isolates from the same site.

Authors:  P E Kolenbrander; Y Inouye; L V Holdeman
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

9.  Prevalence of viridans streptococci exhibiting lactose-inhibitable coaggregation with oral actinomycetes.

Authors:  P E Kolenbrander; B L Williams
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

  9 in total
  4 in total

1.  Lytic bacteriophages ofStreptococcus mutans.

Authors:  A L Delisle; C A Rostkowski
Journal:  Curr Microbiol       Date:  1993-09       Impact factor: 2.188

2.  Use of lytic bacteriophage for Actinomyces viscosus T14V as a probe for cell surface components mediating intergeneric coaggregation.

Authors:  A L Delisle; J A Donkersloot; P E Kolenbrander; C A Tylenda
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

3.  Multigeneric aggregations among oral bacteria: a network of independent cell-to-cell interactions.

Authors:  P E Kolenbrander; R N Andersen
Journal:  J Bacteriol       Date:  1986-11       Impact factor: 3.490

4.  Isolation of Actinomyces bacteriophage from human dental plaque.

Authors:  C A Tylenda; C Calvert; P E Kolenbrander; A Tylenda
Journal:  Infect Immun       Date:  1985-07       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.